About

Letter From the Chair

“Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources.

Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.

The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 5 pharmacy colleges.”


Annual Report

FROM THE CHAIR

“This year, combined productivity has resulted in more studies, more publications and more impact on public health.”

Almut Winterstein, R.PH., PH.D., FISPE | Professor and Chair

Dr Winterstein, blue hexagon background

Department Highlights

30 Ph.D. Students And over 150 M.S. students

30 Manuscripts First-authored by graduate students

37 Countries Represented Diverse student population

18 Active Projects Extramurally Funded


UF and the World

The University of Florida has made international outreach and collaboration a central theme of its strategic plan and we think about gators as citizens of the world. This past academic year, UF was home to more than 6,800 international students from 138 countries and hosted 1,500 visiting scholars from 89 countries. Internationally-focused research generated close to $300 million for UF. Please check out UF’s report on international activity. POP has faculty from 4 continents and a broad geographic mix of students.

UF and Diversity

The department of Pharmaceutical Outcomes and Policy is proud of its inclusiveness and condemns racism and any other form of discrimination against social groups. Each of us individually and as members of a research community devoted to improve public health, needs to confront these threats with all our abilities. As department, we strive to recruit and support the greatest talent regardless of race, ethnicity, cultural background, religion or spiritual belief or sexual orientation. Read here how UF has re-emphasized its commitment to foster diversity and equity among its students, faculty and staff as outlined in its strategic plan with new actions against racism.